UPDATE: Morgan Stanley Downgrades Amgen (AMGN) to Equalweight
Tweet Send to a Friend
(Updated - September 7, 2021 4:48 AM EDT)
Morgan Stanley analyst Matthew Harrison downgraded Amgen (NASDAQ: AMGN) from Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Matthew Harrison downgraded Amgen (NASDAQ: AMGN) from Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
